Nextleaf Options, a top cannabis extraction technologies enterprise, has announced these days that it has added Dr. Sherry Boodram, former Senior Regulatory Compliance Officer with Wellness Canada, to its Board of Directors, efficient instantly.
Dr. Sherry Boodram worked for the Canadian federal government for various years and was accountable for licensing application critiques and on-web-site facility inspections of Canadian cannabis business facilities.
Dr. Boodram also offered field level input through the drafting of the existing Canadian cannabis regulations.
“Being a enterprise with values I can stand behind, I’m pretty excited to serve alongside Nextleaf’s current Board members and with their talented executive group,” stated Dr. Sherry Boodram. “Moreover, I appear forward to maximizing the one of a kind understanding and practical experience I gained even though at Wellness Canada’s Health-related Cannabis Plan, and in the cannabis business as a entire, to offer experience in help of Nextleaf’s ongoing commitment to regulatory compliance, fantastic governance, and lengthy-term development as a leader in cannabis extraction technologies.”
Dr. Boodram holds a Ph.D. in Chemistry from York University, a B.Sc. (Hon) from the University of Toronto, and a Graduate Certificate with Honours in Pharmaceutical Regulatory Affairs and Good quality Operations from Seneca College. Dr. Boodram is also a member of the Canadian Association of Specialists in Regulatory Affairs (CAPRA).
At the moment, Dr. Boodram is the co-founder and CEO of CannDelta Inc. (“CannDelta”) – a regulatory and scientific cannabis consulting enterprise primarily based out of Toronto, Canada – exactly where she offers regulatory experience and develops approaches to assure regulatory compliance inside Canada’s current legal cannabis framework.
“The significant regulatory infractions by various significant Canadian licensed cannabis producers, along with an expanded scope of cannabis goods via legalization two., reinforces the crucial part that compliance oversight plays in developing a cannabis enterprise all stakeholders can be proud of,” stated Paul Pedersen, co-founder and CEO of Nextleaf Options. “Sherry is amongst the most credible and certified cannabis regulatory professionals in Canada, and we think her background, insights, and business practical experience will add tremendous worth to our Board.”
About Nextleaf Options
Nextleaf Options Ltd. (“OILS”) is building disruptive intellectual home for industrial-scale extraction, purification, and formulation of cannabinoids. OILS owns a portfolio of eight (eight) issued and 35 pending patents pertaining to the production of higher-purity, cannabinoid-wealthy distillate, the essential ingredient applied in the manufacturing of standardized THC and CBD infused goods. As soon as cannabis concentrates and edibles turn into legal across Canada, OILS plans to commercialize its intellectual home portfolio via IP licensing, B2B processing solutions, and the provide of THC and CBD oils and concentrates to certified Canadian and international partners.
Nextleaf Options trades as OILS on the Canadian Securities Exchange (CSE: OILS), OILFF on the OTCQB Market place in the United States (OTCQB: OILFF) and L0MA on the Frankfurt Stock Exchange (FSE: L0MA).
For extra information and facts check out www.nextleafsolutions.com or comply with OILS across social media platforms: Twitter, LinkedIn, Facebook, and Instagram.